Cet anticorp Influenza A Virus Neuraminidase est non-conjugé
Application
ELISA
Specificité
Virus
Purification
Avian Influenza A H7N9 Neuraminidase antibody is affinity chromatography purified via peptide column.
Immunogène
Avian Influenza A H7N9 Neuraminidase antibody was raised against a synthetic peptide corresponding to 11 amino acids near the amino terminus of the H7N9 [Influenza A virus (A/Shanghai/02/2013(H7N9))] Neuraminidase protein. The immunogen is located within amino acids 50 - 100 of Avian Influenza A H7N9 Neuraminidase.
NA
Reactivité: Influenza A Virus H5N1
WB
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Avian Influenza A H7N9 Neuraminidase antibody can be used for detection of Avian Influenza A H7N9 Neuraminidase by ELISA at 1 μ,g/mL.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Avian Influenza A H7N9 Neuraminidase Antibody is supplied in PBS containing 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C,4 °C
Stockage commentaire
Avian Influenza A H7N9 Neuraminidase antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Antigène
Influenza A Virus Neuraminidase (NA)
Autre désignation
Avian Influenza A H7N9 Neuraminidase (NA Produits)
Classe de substances
Influenza Protein
Sujet
Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals, however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).